DDW 2019: Budesonide Orodispersible Tablets Maintain Clinicohistological Remission in Eosinophilic Esophagitis
Overall, 48 weeks of either the 1 or 0.5 mg twice-daily dose proved safe and highly effective vs placebo.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.